Life Sciences Tools and Services
Company Overview of Pharmidex Ltd.
Pharmidex Ltd. operates a centre for studying central nervous system (CNS) drug distribution and biochemical responses to new drugs. It offers in vitro, in situ, in vivo CNS, ADMET, and PK solutions, as well as consultancy solutions. The company also provides bio-analytical solutions that enable to determine small and large molecules and biomarkers in tissues and biological fluids; and Cerense, a product development platform to improve the development of CNS medicines that normally exhibit poor permeation of the blood brain barrier. It serves clients who develop medicines for CNS diseases. The company was founded in 2002 and is based in London, the United Kingdom.
72 New Bond Street
London, W1S 1RR
Founded in 2002
44 8702 405 978
44 8451 259 586
Key Executives for Pharmidex Ltd.
Similar Private Companies By Industry
|14M Genomics Ltd||Europe|
|Ablatus Therapeutics Limited||Europe|
|Accuro Biologics Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Pharmidex Ltd., please visit www.pharmidex.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.